First Time Loading...

Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 5.74 AUD -9.89% Market Closed
Updated: May 20, 2024

Mayne Pharma Group Ltd
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mayne Pharma Group Ltd
Accounts Payable Peer Comparison

Comparables:
RCE
NEU
BOT
PBP
C
CU6

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
Mayne Pharma Group Ltd
ASX:MYX
Accounts Payable
AU$32m
CAGR 3-Years
2%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Accounts Payable
AU$1.7m
CAGR 3-Years
41%
CAGR 5-Years
80%
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Accounts Payable
AU$3.4m
CAGR 3-Years
66%
CAGR 5-Years
12%
CAGR 10-Years
5%
Botanix Pharmaceuticals Ltd
ASX:BOT
Accounts Payable
AU$1.3m
CAGR 3-Years
-1%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Probiotec Ltd
ASX:PBP
Accounts Payable
AU$30.7m
CAGR 3-Years
41%
CAGR 5-Years
18%
CAGR 10-Years
9%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Accounts Payable
AU$2.8m
CAGR 3-Years
163%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Mayne Pharma Group Ltd's Accounts Payable?
Accounts Payable
32m AUD

Based on the financial report for Jun 30, 2023, Mayne Pharma Group Ltd's Accounts Payable amounts to 32m AUD.

What is Mayne Pharma Group Ltd's Accounts Payable growth rate?
Accounts Payable CAGR 5Y
-13%

Over the last year, the Accounts Payable growth was -50%. The average annual Accounts Payable growth rates for Mayne Pharma Group Ltd have been 2% over the past three years , -13% over the past five years .